About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Tusaldah Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
09-Feb-2026
12-Feb-2026
Quarterly Results
11-Nov-2025
14-Nov-2025
Quarterly Results
07-Aug-2025
13-Aug-2025
Voluntary Delisting of Shares & Quarterly Results
20-Jun-2025
26-Jun-2025
Inter alia, to consider and approve :- 1. To consider and approve the appointment of Additional Directors of the Company; 2. To consider and approve the resignation of Directors of the Company; 3. To consider and approve the Reclassification of Outgoing Promoters on account of open offer; 4. To consider and approve the appointment of Company Secretary and Compliance officer of the Company; 5. To consider and approve the Change of name of the Company; 6. To consider and approve the Shifting of Registered Office from the State of Rajasthan to the State of Maharashtra; 7. To consider and approve the appointment of Statutory Auditor of the Company for the year 2025-26; 8. To consider and approve the appointment of Internal Auditor of the Company for the year 2025-26; 9. Any other matter with the permission of the Chair.
19-May-2025
24-May-2025
Audited Results
27-Jan-2025
03-Feb-2025
Quarterly Results
17-Jan-2025
24-Jan-2025
Inter alia, to consider and approve:- 1. To discuss and consider alteration in the Articles of Association of the Company subject to approval of shareholders. 2. To discuss and consider increase in Authorized Share Capital of the Company subject to approval of shareholders. 3. The proposal for fund raising by way of preferential issue / private placement of securities for cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 4. To discuss and consider alteration of main object clause of the Memorandum of Association of the Company, subject to approval of shareholders; 5. To discuss and consider the shifting of registered office of the Company. 6. To discuss and consider Borrowing money in excess of paid-up share capital, free reserves, and securities premium under Section 180(1)(c) of the Companies Act, 2013.
05-Nov-2024
12-Nov-2024
Quarterly Results
01-Aug-2024
09-Aug-2024
Quarterly Results
17-May-2024
08-May-2024
02-May-2024
08-May-2024
Audited Results
20-Jan-2024
29-Jan-2024
Increase in Authorised Capital & Preferential Issue of shares & Quarterly Results
30-Oct-2023
06-Nov-2023
Quarterly Results
27-Jul-2023
04-Aug-2023
Quarterly Results
17-May-2023
25-May-2023
Audited Results
02-Feb-2023
10-Feb-2023
Quarterly Results
07-Nov-2022
12-Nov-2022
Quarterly Results
03-Aug-2022
12-Aug-2022
Quarterly Results
17-May-2022
25-May-2022
Audited Results
31-Jan-2022
10-Feb-2022
Quarterly Results
Page
1
of
5
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.